Gastroenterology Research and Practice / 2009 / Article / Tab 2

Clinical Study

Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life

Table 2

Sickness impact profile, SIP (0% Best).

( )1st year2nd year

BaselineWeek 13Week 26Week 52WashoutWeek 13Week 26Week 52P-value

TreatmentNoneGLP-2GLP-2GLP-2NoneGLP-2GLP-2 + Cholyl-sarcosineGLP-2
Body care and movement
Physical Dimension
Emotional behaviour
Social interaction
Alertness behaviour
Psychosocial Dimension
Sleep and rest
Home management
Recreation and pastimes
Independent Categories
QOL VAS-score, 0–9 cm, 9 cm best * * * * * * * 0.01

QOL VAS-score Quality of life Visual Analog Scale, * compared to baseline by Dunnett’s test, compared to baseline by chi-square, alternatively Fisher exact test.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.